DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Women's Health Homepage

New bill calls for dense breast tissue notification in patient-received mammo reports Would set a minimum federal standard

Konica Minolta signs group purchasing agreement with Premier for the Exa platform The three-year deal brings special pricing to 3,900 hospitals

MGH first to purchase GE's patient-assisted mammo compression device Pristina Dueta aims at reducing patient anxiety, discomfort

Clinical trial combining focused ultrasound and immunotherapy underway Aim is to enhance the ability of the immune system to recognize tumors

CureMetrix's new CAD software leverages machine learning Not yet FDA approved

New machine learning tool identifies breast lesions likely to become cancerous May help reduce unnecessary surgical procedures

Researchers to assess benefits of 3-D mammo versus 2-D Will follow 165,000 women between ages 45 and 74 through at least 2025

Hypofractionated whole-breast radiotherapy best for early-stage breast cancer patients under 50 Study supports higher dose, shorter form treatment

Study finds mobile mammo patients aren't getting the follow-up imaging they need Socioeconomic factors credited for low adherence rates

Hologic launches SmartCurve breast stabilization system for U.S. consumers A more comfortable mammogram without compromised image quality

Purchasing Insights: Market trends in women’s health

By Julie Johnson
From the July 2017 issue of DOTmed HealthCare Business News magazine
Analyst, MD Buyline

The women’s health market is very active and continues to grow, especially since the introduction of digital breast tomosynthesis (DBT) technology in 2011 by Hologic.

Over the past several years only a few other vendors have entered the DBT market, making it highly competitive.

Story Continues Below Advertisement

qualiTEE - reliabiliTEE - repairabiliTEE - we guaranTEE

Bayer HealthCare Multi Vendor Service will repair your transducer with the same precision and care you provide to your patients. Now offering TotalREPAIR on 140 transducer models! Call us at 1-844-5100 or visit www.mvs.bayer.com to set up an order today.



The major players in the DBT mammography market include Hologic, GE Healthcare and Siemens. These three vendors have been competing for market share now that each has added a dedicated DBT system to its product lineup. Fuji introduced its Aspire Cristalle DBT system in January 2017. With the addition of Fuji’s platform, there is now a much needed boost of competition entering the 3-D mammography market.

The trend has continued over the past several years, with DBT remaining the primary technology of interest when considering a mammography system. Clinical trials continue to show the benefits of using a 3-D system over a conventional 2-D full-field digital system. Studies continue to demonstrate that 3-D mammograms find more cancers and also diminish the number of false positives.

MD Buyline quote activity shows a steep decline in interest for 2-D full-field digital systems. The market reflects a combination of more highly configured DBT systems that include CAD, 2-D synthesized imaging software, advanced workstations and breast biopsy, as well as more basic configurations, depending on budget constraints and facility needs.

Pricing for a 2-D system is approximately $300,000 for a standard configuration. Pricing for a 3-D system ranges on average from $400,000 to $450,000. However, the steeper price tag has not been a deterrent for facilities wanting to purchase a highly sought-after 3-D system.

Facilities considering a mammography system often bundle their purchases with other women’s health equipment such as a biopsy or bone density system. Since the April 2016 release of Hologic’s prone biopsy table, which offers 3-D image quality, interest and quote activity have continued to grow for this platform. However, based on MD Buyline quoting activity, customers also still frequently express interest in purchasing the 2-D upright system as an addition to their new DBT mammography system. Hologic is the only vendor tracked by MD Buyline for breast biopsy.

Bone density systems are a small, but important, part of the women’s health market, especially for those patients at risk for osteoporosis and bone fracture. The two active vendors in this market are Hologic and GE Healthcare, with competition between the two remaining fairly even. Fan-beam technology is the main segment of interest for the majority of customers. A very small portion of the activity is still focused on peripheral scanners. The latest area of interest in bone density technology remains Fracture Risk Assessment (FRAX) and metabolic DEXA scan for body composition, which measures visceral fat and can help assess risk factors for obesity and other metabolic conditions.
  Pages: 1 - 2 >>

Women's Health Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED